Search by Drug Name or NDC

    NDC 66993-0269-30 Amlodipine and Atorvastatin 5; 80 mg/1; mg/1 Details

    Amlodipine and Atorvastatin 5; 80 mg/1; mg/1

    Amlodipine and Atorvastatin is a ORAL TABLET, COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Prasco Laboratories. The primary component is AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE.

    Product Information

    NDC 66993-0269
    Product ID 66993-269_ef500e60-46ea-4722-945b-2b4549fd36b8
    Associated GPIs 40992502150335
    GCN Sequence Number 053692
    GCN Sequence Number Description amlodipine/atorvastatin TABLET 5 MG-80 MG ORAL
    HIC3 M4I
    HIC3 Description ANTIHYPERLIPID- HMG-COA RI-CALCIUM CHANNEL BLOCKER
    GCN 21394
    HICL Sequence Number 025951
    HICL Sequence Number Description AMLODIPINE BESYLATE/ATORVASTATIN CALCIUM
    Brand/Generic Generic
    Proprietary Name Amlodipine and Atorvastatin
    Proprietary Name Suffix n/a
    Non-Proprietary Name Amlodipine and Atorvastatin
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, COATED
    Route ORAL
    Active Ingredient Strength 5; 80
    Active Ingredient Units mg/1; mg/1
    Substance Name AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE
    Labeler Name Prasco Laboratories
    Pharmaceutical Class Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors
    DEA Schedule n/a
    Marketing Category NDA AUTHORIZED GENERIC
    Application Number NDA021540
    Listing Certified Through 2024-12-31

    Package

    NDC 66993-0269-30 (66993026930)

    NDC Package Code 66993-269-30
    Billing NDC 66993026930
    Package 30 TABLET, COATED in 1 BOTTLE (66993-269-30)
    Marketing Start Date 2022-03-14
    NDC Exclude Flag N
    Pricing Information N/A